Intelligent Medicine®

ENCORE: A New Revolutionary Technology That Can Predict Cardiovascular Risk With Precision, Part 1

Current ways of visualizing the coronary arteries with calcium scoring are limited: the presence of calcium doesn’t always determine risk; its absence doesn’t fully eliminate the possibility of soft plaque, which is actually more dangerous than stable calcium deposits. Dr. James Min is an expert on cardiovascular imaging and founder and CEO of Cleerly, a company that has developed an improved scan that can differentiate between dangerous unstable plaque, and more benign lesions. The test can be used to establish risk, and then medication and/or lifestyle modification with diet, stress reduction, exercise and supplements can be undertaken. Subsequent tests can yield a report card for how successful the preventive interventions have been. Dr. Min emphasizes that even in settings of high cholesterol the test can show minimal risk, reducing the need for cholesterol medication; conversely, people with low cholesterol may have substantial dangerous plaque. The Cleerly test promises to revolutionize our approach to cardiovascular prevention. Click HERE for part 2.

You may also like...

Featured Article
Latest Podcast
Featured Product

Finally a reason to switch your omega-3!

You’ve heard me talk for years about the importance of including fish oil in your supplement regimen—but not all omega-3s are created equal. 

I’m excited to share that I’ve made the switch to a formulation that tops all the rest: Big Bold Health’s Omega-3 Rejuvenate is a premium blend of oils from wild-caught Alaskan cod and sockeye salmon. 

Using a low heat extraction technique to extract the pure amber oil that contains all-natural and abundant full-spectrum omega-3s, Omega-3 Rejuvenate preserves the natural goodness of the fish, so you get maximum benefits in every soft gel. 

Right now, you can save 20% on your order with code HOFFMAN20.

Learn more…